Clinical Trial Update: Dapagliflozin and Renal Surrogate Outcomes in Advanced Chronic Kidney Disease [Phase 3]

View source ↗

Summary

This document reports an update on a Phase 3 trial evaluating dapagliflozin for renal surrogate outcomes in advanced chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Kaohsiung Medical University | Conditions: Chronic Kidney Diseases | Phase 3 | Status: COMPLETED